Stay updated on Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The revision badge on the page updated from v3.6.0 to v3.6.2, signaling a platform release. No study data or navigation elements appear to be changed.
    Difference
    0.0%
    Check dated 2026-06-29T08:54:03.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The recruitment status changed to not actively recruiting participants, and the record history shows a new software revision (v3.6.0) with the prior revision (v3.5.5) removed.
    Difference
    0.2%
    Check dated 2026-06-15T05:35:48.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.5.5 as the latest entry, replacing the previous Revision: v3.5.4.
    Difference
    0.0%
    Check dated 2026-06-08T03:48:30.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing v3.5.3. This indicates a minor platform update to the page.
    Difference
    0.0%
    Check dated 2026-05-17T08:41:10.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page’s displayed interface/version label has been updated from “v3.5.0” to “v3.5.3,” indicating a site revision rather than a change to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-25T18:25:02.000Z thumbnail image
  7. Check
    108 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed in the study history. This is a minor version-tracking update and does not modify study data or page content.
    Difference
    0.0%
    Check dated 2026-03-20T19:48:26.000Z thumbnail image

Stay in the know with updates to Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.